Investigating how certain proteins affect metabolism and immune response in tuberculosis

Sirtuins and Host Metabolism in TB Pathogenesis and Treatment

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10816617

This study is looking at how certain proteins in your immune cells change when you have tuberculosis (TB) and how these changes can affect inflammation and the severity of the disease, with the goal of finding new ways to help improve treatment for TB patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10816617 on NIH RePORTER

What this research studies

This research focuses on understanding the role of sirtuins, a family of proteins, in the metabolism and immune response of patients with tuberculosis (TB). It examines how Mycobacterium tuberculosis infection alters the function of these proteins in immune cells, leading to increased inflammation and disease severity. By analyzing the metabolic changes in these cells, the research aims to identify potential therapeutic targets that could improve treatment outcomes for TB patients. The approach includes laboratory studies using infected immune cells to explore the underlying mechanisms of TB pathogenesis.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with tuberculosis, particularly those experiencing severe symptoms or complications.

Not a fit: Patients with non-infectious lung diseases or those who have not been diagnosed with tuberculosis may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatment strategies that enhance the immune response and reduce lung damage in TB patients.

How similar studies have performed: Previous research has shown promising results in targeting metabolic pathways in infectious diseases, suggesting that this approach may yield beneficial outcomes.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.